Decrease in Natural Killer cell associated gene expression as a major characteristic of the immune status in the bloodstream of colorectal cancer patients

Cancer Biology and Therapy

Volumn 11, Issue 2, 2011, Pages 188-195

  Xu, Ye ^a   Xu, Qing Hua ^a,b,c   Ni, Shu Juan ^a   Liu, Fang ^b,c   Cai, Guo Xiang ^a   Wu, Fei ^b,c   Ye, Xun ^b,c   Meng, Xia ^c   Mougin, Bruno ^d   Cai, San Jun ^a   Du, Xiang ^a,c  

^a Institut Mérieux Laboratory   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c FUDAN UNIVERSITY   (China)

^d BIOMÉRIEUX   (France)

Author keywords

Biomarker; Colorectal cancer; Gene expression profiling; Microarray; Natural killer cell; Peripheral blood

Indexed keywords

BIOLOGICAL MARKER; DNA; RNA;

ADULT; ARTICLE; BACTERIAL GENE; BLOOD; BLOOD SAMPLING; BLOODSTREAM INFECTION; CANCER PATIENT; CELL COMMUNICATION; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENETIC HETEROGENEITY; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOCOMPETENT CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; RNA EXTRACTION;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; DOWN-REGULATION; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 78751477876     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.2.13670     Document Type: Article

References (22)

1. Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005; 14:243-50.
2. Prevention DOSM. The incident of malignant tumors in Shanghai Area for 2006. Shanghai Journal of Preventive Medicine 2010; 22:53.
3. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Costeffectiveness of screening for colorectal cancer in the general population. JAMA 2000; 284:1954-61.
4. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2010; 60:99-119.
5. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000; 133:573-84.
6. Yamamoto M, Nakama H. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods. Hepatogastroenterology 2000; 47:396-9.
7. Han M, Liew CT, Zhang HW, Chao S, Zheng R, Yip KT, et al. Novel blood-based, five-gene biomarker set for the detection of colorectal cancer. Clin Cancer Res 2008; 14:455-60.
8. Marshall KW, Mohr S, Khettabi FE, Nossova N, Chao S, Bao W, et al. A blood-based biomarker panel for stratifying current risk for colorectal cancer. Int J Cancer 2010; 126:1177-86.
9. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, et al. The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006; 24:1151-61.
10. Trapani JA, Sutton VR. Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr Opin Immunol 2003; 15:533-43.
11. Spurkland A, Brinchmann JE, Markussen G, Pedeutour F, Munthe E, Lea T, et al. Molecular cloning of a T cell-specific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sites. J Biol Chem 1998; 273:4539-46.
12. Qiu H, Xiao-Jun W, Zhi-Wei Z, Gong C, Guo-Qiang W, Li-Yi Z, et al. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer. Hepatogastroenterology 2009; 56:1310-5.
13. Aparicio-Pages NM, Verspaget HW, Pena SA, Lamers CB. Impaired local natural killer cell activity in human colorectal carcinomas. Cancer Immunol Immunother 1989; 28:301-4.
14. Kondo E, Koda K, Takiguchi N, Oda K, Seike K, Ishizuka M, et al. Preoperative natural killer cell activity as a prognostic factor for distant metastasis following surgery for colon cancer. Dig Surg 2003; 20:445-51.
15. Furue H, Matsuo K, Kumimoto H, Hiraki A, Suzuki T, Yatabe Y, et al. Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese. Carcinogenesis 2008; 29:316-20.
16. Zamai L, Ponti C, Mirandola P, Gobbi G, Papa S, Galeotti L, et al. NK cells and cancer. J Immunol 2007; 178:4011-6.
17. Mozaffari F, Lindemalm C, Choudhury A, Granstam-Bjorneklett H, Helander I, Lekander M, et al. NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo-and radiotherapy. Br J Cancer 2007; 97:105-11.
18. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4:249-64.
19. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 8:118-27.
20. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98:5116-21.
21. Team RDC. R: A Language and Environment for Statistical Computing. Vienna, Austria 2009.
22. Wilson CL, Miller CJ. Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics 2005; 21:3683-5.